NFKB1 and colorectal cancer: For instance, human colorectal cancer cells (SW480, LoVo, and HT29) treated with SB (50–200 μM) demonstrated reduced TNF-α-induced NF-κB activation together with decreased nuclear levels of both p65 and p50 sub-units.